
1. Nihon Yakurigaku Zasshi. 2015 Sep;146(3):159-70. doi: 10.1254/fpj.146.159.

[Preclinical and clinical properties of vaniprevir (VANIHEP® Capsules 150 mg), a 
novel therapeutic agent for hepatitis C].

[Article in Japanese]

Kinoshita K, Iwasa T, Takase A, Nakamura K.

DOI: 10.1254/fpj.146.159 
PMID: 26354016  [Indexed for MEDLINE]

